For example, consistent with published reports demonstrating a strong IL‐17A signature in ERA (9), we found an increase in IL‐17A–producing CD4+, CD8+, and CD4−CD8− T cells in SFMCs isolated from patients with ERA (Figures 3A–C). The gene discussed is CD4; the disease is enthesitis-related juvenile idiopathic arthritis.